First Time in Man Trial for Friulimicin B

Clinical trial NCT00492271 · TERMINATED

Trial details

NCT number: NCT00492271
Sponsor: MerLion Pharmaceuticals GmbH
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Community Acquired Pneumonia Staphylococcal Skin Infections

Start date: 2007-06-01
Primary completion: 2007-09-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.